Cargando...

Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome

OBJECTIVE: The European Increlex(®) Growth Forum Database Registry monitors the effectiveness and safety of recombinant human insulin-like growth factor-1 (rhIGF1; mecasermin, Increlex(®)) therapy in patients with severe primary IGF1 deficiency (SPIGFD). We present data from patients with and withou...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Eur J Endocrinol
Autores principales: Bang, Peter, Woelfle, Joachim, Perrot, Valerie, Sert, Caroline, Polak, Michel
Formato: Artigo
Lenguaje:Inglês
Publicado: Bioscientifica Ltd 2020
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7849377/
https://ncbi.nlm.nih.gov/pubmed/33434161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EJE-20-0325
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!